A Prospective Randomized Clinical Trial of Vincristine versus Human Intravenous Immunoglobulin for Acute Adjunctive Management of Presumptive Primary Immune-Mediated Thrombocytopenia in Dogs
Journal of Veterinary Internal Medicine2013Vol. 27(3), pp. 536–541
Citations Over TimeTop 20% of 2013 papers
Kelley A. Balog, Andy Huang, S.O Sum, George E. Moore, Craig A. Thompson, J. Catharine Scott‐Moncrieff
Abstract
Vincristine should be the first-line adjunctive treatment for the acute management of canine ITP because of lower cost and ease of administration compared with human intravenous immunoglobulin (hIVIG).
Related Papers
- → Clinical Outcome and its Predictors in Children With Newly Diagnosed Immune Thrombocytopenia(2024)4 cited
- Immunosuppressive efficacy of vincristine in heart transplantation: a preliminary report.(1988)
- → Modified Combination Chemotherapy of Leukemia(1983)
- [Electroencephalographic observations after therapy with vincristine (author's transl)].(1978)
- 포스터 6 : Vincristine-Loaded Platelet Infusion 제조경험(2015)